Zacks.com on MSN
Here's Why You Should Retain Masimo Stock in Your Portfolio Now
MASI's strong Q3 2025 results, FDA clearance and partnerships fuel growth hopes, but SET dependence and reimbursement risks ...
Masimo (NASDAQ: MASI) today announced that its management will participate in the J.P. Morgan 2026 Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m. Pacific time. A live webcast of the ...
Mixed bag of news for Apple as Masimo tumbles in quality despite patent win, on-device AI threatens data centers, and the Tim ...
Zacks Investment Research on MSN
Owlet's data flywheel grows: Can AI boost lifetime value?
Owlet, Inc. OWLT is steadily transforming from a connected baby monitor brand into a data-driven pediatric health platform, ...
FDA plans limited regulation of wearable medical devices, boosting Apple, Fitbit, Oura stocks as 50% of Americans use fitness ...
The Skincubator is a wearable designed to enable immediate, prolonged skin-to-skin care for the tiniest preterm infants in ...
Capnography is a medical monitoring device capable of non-invasively measuring partial CO2 levels by plotting a capnograph on the x and y-axis. These devices are categorized as mainstream, microstream ...
The global respiratory device market witnessed substantial growth, reaching USD 15.8 billion in 2020 and is projected to reach USD 38.0 billion by 2027, with a notable CAGR of 13.5% during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback